Clinical Trial Update: A Study of the Biodistribution and Safety of [18F]GTP1 in Healthy Japanese Participants [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating biodistribution and safety of a radiotracer [18F]GTP1 in healthy Japanese participants; completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• [18F]GTP1 (18F-labeled tracer GTP1)

Snippet

Sponsor: Genentech, Inc. | Conditions: Alzheimer Disease | Phase 1 | Status: COMPLETED | Results posted: 2021-11-03